Ongoing clinical assessment should be performed for symptomatic CMV infection during MabCampath treatment and for at least 2 months following completion of treatment.
Der bør foretages løbende klinisk vurdering for symptomatisk CMV- infektion under behandling med MabCampath i mindst 2 måneder efter afsluttet behandling.